Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > EU project targets MRSA infections

MRSA bacteria
 Shutterstock
MRSA bacteria Shutterstock

Abstract:
Hospitals and other healthcare facilities house Staphylococcus aureus bacteria (i.e. 'staph') that trigger MRSA (methicillin-resistant Staphylococcus aureus) infections. The problem is that not only is MRSA resistant to antibiotics, but it can also be fatal. A team of European researchers is ready to tackle the problem by finding ways to reduce MRSA infection rates in hospitals worldwide. The project is supported by the EU under the Seventh Framework Research Programme with EUR 5 million in funding.

EU project targets MRSA infections

Europe | Posted on November 17th, 2008

'The spread of drug-resistant germs such as MRSA is a major public health concern,' explained Dr Tofail Syed from the University of Limerick. 'A significant element of the MRSA problem arises from the use of conventional textiles such as hospital gowns, curtains, beddings and pillow covers. As a result, hospital sterility has been a major concern in countries like Ireland, Germany and Belgium.'

The group will tackle this problem by using nanotechnology to develop MRSA-resistant textiles that are self- sterilising and developed to kill bacteria. In this way, hospitals have a means of fighting bacterial infection.

Experts believe that drug-resistant microbes like MRSA cause infections in 1 in 10 people in European hospitals. Each year, more than 3 million people in the EU develop hospital-based infections, and around 50 000 patients die from them.

'In southern and western Europe, over 40% of hospitals have significant problems with the MRSA super bug,' Professor Syed noted. 'We are confident of redressing this statistic through our research and development of MRSA-resistant textiles.'

Besides targeting MRSA-resistant textile development, the three-year project is spotlighting three other areas of European healthcare affecting life quality: plaque-resistant cardiovascular stents (metal structures that are placed on the inside of blocked arteries); urinary stents that cause less stone formation; and bone implants that heal faster.

'The project addresses four major areas of European healthcare that affect the quality of life of European citizens and cost European states considerable amounts of money,' commented Mr Liam Brown, head of Research Support at the University of Limerick. 'In particular, cardiovascular disease is the cause of half of (the) deaths in Europe, accounting for in excess of 2 million deaths per year. Arterial thrombosis contributes significantly and the project will directly address this issue.'

The University of Limerick will lead European agencies and enterprises in this project.

'The awarding of the EUR 5 million contract to the University of Limerick is a testament of Ireland's role as a leading R&D centre for the worldwide biomedical sector,' underlined Dr Edmond Magner, head of the Materials and Surface Science Institute (MSSI) at the University of Limerick.

####

For more information, please click here

Copyright © European Commission

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Synthesize Stable Ceramic Nanopowders at Room Temperature September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

Govt.-Legislation/Regulation/Funding/Policy

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Big Results Require Big Ambitions: Three young UCSB faculty receive CAREER awards from the National Science Foundation September 18th, 2014

Scientists refine formula for nanotube types: Rice University theorists determine factors that give tubes their chiral angles September 17th, 2014

New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014

Nanomedicine

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

The Pocket Project will develop a low-cost and accurate point-of-care test to diagnose Tuberculosis: ICN2 holds a follow-up meeting of the Project on September 18th - 19th September 18th, 2014

New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014

Recruiting bacteria to be technology innovation partners: September 17th, 2014

Announcements

Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE